NCT00556465View on ClinicalTrials.gov

Efficacy of N-Acetylcysteine in Treatment of Overt Diabetic Nephropathy

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 31, 2007

Study Completion Date

June 30, 2007

Conditions
Diabetic NephropathyChronic Kidney DiseaseDiabetes Type 2
Interventions
DRUG

N-acetylcysteine

600 mg of effervescent N-acetylcysteine tablet twice per day for three months

Trial Locations (1)

0098711

Mohammad mahdi sagheb, Shiraz

All Listed Sponsors
lead

Shiraz University of Medical Sciences

OTHER

NCT00556465 - Efficacy of N-Acetylcysteine in Treatment of Overt Diabetic Nephropathy | Biotech Hunter | Biotech Hunter